Vergoeding 2019-2023 voor ATC-subgroep B01AC : Trombocytenaggregatieremmers excl heparine
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| B01AC04 Clopidogrel (Plavix ®) | 5.991.300 | 6.789.400 | 7.190.900 | 7.850.400 | 8.825.200 |
| B01AC06 Acetylsalicylzuur (Aspirine protect ®) | 6.768.900 | 6.319.800 | 7.189.400 | 7.271.800 | 8.455.100 |
| B01AC07 Dipyridamol (Persantin ®) | 2.963.600 | 2.603.600 | 2.208.900 | 1.765.400 | 1.100.300 |
| B01AC08 Carbasalaatcalcium (Ascal cardio neuro ®) | 3.580.900 | 3.275.800 | 2.949.700 | 2.826.800 | 2.639.500 |
| B01AC09 Epoprostenol (Veletri ®) | 1.148.500 | 1.107.600 | 1.082.600 | 629.090 | 267.120 |
| B01AC11 Iloprost (Ventavis ®) | 192.510 | 224.990 | 217.590 | 215.750 | 298.460 |
| B01AC21 Treprostinil (Remodulin ®) | 4.447.500 | 3.723.500 | 3.208.400 | 5.088.700 | 4.228.800 |
| B01AC22 Prasugrel (Efient ®) | 1.258.900 | 1.165.500 | 1.182.100 | 1.304.900 | 1.209.100 |
| B01AC24 Ticagrelor (Brilique ®) | 17.245.000 | 16.780.300 | 15.665.200 | 16.344.900 | 16.214.500 |
| B01AC27 Selexipag (Uptravi ®) | 7.971.700 | 8.376.800 | 8.491.500 | 10.170.400 | 10.635.000 |
| B01AC30 Combinatiepreparaten | 1.132.200 | 29.379 | 6.301 | 3.691 | 1.542 |
| Totaal | 52.701.010 | 50.396.669 | 49.392.591 | 53.471.831 | 53.874.622 |